Cover Image

Creating China's Biosimilar Drugs Regulatory System: A Calculated Approach

Saved in:

Bibliographic Details
Main Authors:	Jianhong Yang (Author), Xiaoyu Zhao (Author), Jie Li (Author), Kejian Zhang (Author), Zheru Zhang (Author), Shunwen Chang (Author), Daotian Fu (Author), Xinhuan Lyu (Author), Xianglin Zhang (Author), Ying Shao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

La enseñanza del español en China: análisis de palabras interrogativas de profesores universitarios en clases de español
by: Kejian Qian
Published: (2020)

The impact of psychological stress on physiological indicators in healthcare workers: a cross-sectional study
by: Na Li, et al.
Published: (2024)

Deep cutaneous ulcers and sinus formation in an immunocompetent adult,
by: Qiang Zhou, et al.
Published: (2020)

Association between socio-economic factors and the risk of overweight and obesity among Chinese adults: a retrospective cross-sectional study from the China Health and Nutrition Survey
by: Kai Wang, et al.
Published: (2022)

Uveitis occurring in a patient with psoriasis during adalimumab therapy: A case report
by: Qiaoli Zheng, et al.
Published: (2022)

Traditional Uses, Chemistry, Pharmacology, Toxicology and Quality Control of Alhagi sparsifolia Shap.: A Review
by: Feng Wei, et al.
Published: (2021)

Biosimilars: Current regulatory perspective and challenges
by: Diwakar Jha, et al.
Published: (2013)

On the Regulatory Approval Pathway of Biosimilar Products
by: Jun Wang, et al.
Published: (2012)

A Regulatory Perspective on Biosimilar Medicines
by: Marta Agostinho Cordeiro, et al.
Published: (2024)

Biosimilars: State of Clinical and Regulatory Science
by: Agnes Victoria Klein, et al.
Published: (2018)

A comprehensive review of the literature on CD10: its function, clinical application, and prospects
by: Shudong Wang, et al.
Published: (2024)

Current regulatory and market environment for biosimilars in Serbia
by: Pejović Gordana, et al.
Published: (2014)

Biosimilars in Oncology: Latest Trends and Regulatory Status
by: Deeksha Joshi, et al.
Published: (2022)

P- Hydroxybenzyl Alcohol Alleviates Oxidative Stress in a Nonalcoholic Fatty Liver Disease Larval Zebrafish Model and a BRL-3A Hepatocyte Via the Nrf2 Pathway
by: Jing An, et al.
Published: (2021)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2020)

Characteristics of the gut microbiota in pregnant women with fetal growth restriction
by: Xinzhi Tu, et al.
Published: (2022)

A novel alcohol steamed preparation from Gastrodia elata Blume: Pharmacological assessment of a functional food
by: Lijun Cheng, et al.
Published: (2023)

Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
by: Schiestl M, et al.
Published: (2017)

An Overview of Biosimilars-Development, Quality, Regulatory Issues, and Management in Healthcare
by: Filipa Mascarenhas-Melo, et al.
Published: (2024)

The impact of adult children rural-urban migration on left-behind parents' health: Evidence from China
by: Chi Zhang, et al.
Published: (2022)

Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
by: Beverly Ingram, et al.
Published: (2021)

A Follow-Up Investigation of Mental Health Among Discharged COVID-19 Patients in Wuhan, China
by: Li Li, et al.
Published: (2021)

Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey
by: Yang Hu, et al.
Published: (2022)

Biosimilars: A Comparative Study of Regulatory, Safety and Pharmacovigilance Monograph in the Developed and Developing Economies
by: Zarina Iqbal, et al.
Published: (2022)

Regulatory considerations for paediatric drug evaluation in China
by: Hao Zhang, et al.
Published: (2023)

Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines
by: Maarten Van Baelen
Published: (2015)

Regulatory utility of pharmacometrics in the development and evaluation of antimicrobial agents and its recent progress in China
by: Ming Zhao, et al.
Published: (2021)

Flurbiprofen Axetil Enhances Analgesic Effects of Sufentanil and Attenuates Postoperative Emergence Agitation and Systemic Proinflammation in Patients Undergoing Tangential Excision Surgery
by: Wujun Geng, et al.
Published: (2015)

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices
by: Hasumati Rahalkar, et al.
Published: (2021)

Uptake of biosimilars in China: a retrospective analysis of the case of trastuzumab from 2018 to 2023
by: Qiyou Wu, et al.
Published: (2024)

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China
by: Qiyou Wu, et al.
Published: (2023)

Biosimilars
Published: (2022)

Biosimilars
by: Emel Bülbül Başkan
Published: (2022)

Epidemic of chronic diseases and the related healthy lifestyle interventions in rural areas of Shandong Province, China
by: Juncheng Lyu, et al.
Published: (2020)

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
by: Zhen Zeng, et al.
Published: (2024)

A promising choice in hypertension treatment: Fixed-dose combinations
by: Xinhuan Wan, et al.
Published: (2014)

The translation and validation of the Organ Transplant Symptom and Well-Being Instrument in China
by: Ying Shi, et al.
Published: (2022)

The translation and validation of the Organ Transplant Symptom and Well-Being Instrument in China.
by: Ying Shi, et al.
Published: (2022)

Construction of miRNA-mRNA regulatory network indicates potential biomarkers for primary open-angle glaucoma
by: Xiaoyu Zhou, et al.
Published: (2023)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
by: Alina Uifălean, et al.
Published: (2018)